Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Yeast Signaling01:28

Yeast Signaling

17.3K
Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
17.3K
Inflammation01:38

Inflammation

62.4K
Overview
62.4K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

8.7K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impella Protected Percutaneous Coronary Intervention Outcomes Compared With Intra-aortic Balloon Pump: A Contemporary View.

The American journal of cardiology·2026
Same author

A unique case of sepsis-triggered reverse Takotsubo cardiomyopathy resulting in cardiogenic shock.

Archive of clinical cases·2025
Same author

Outcomes of Percutaneous Mechanical Aspiration in Right-Sided Infective Endocarditis: A Multicenter Registry.

Journal of the American College of Cardiology·2025
Same author

Paclitaxel-Coated Balloon for the Treatment of Multilayer In-Stent Restenosis: AGENT IDE Subgroup Analysis.

Journal of the American College of Cardiology·2025
Same author

Advanced Steering Maneuvers for Special Situations in Mitral Valve Transcatheter Edge-to-edge Repair.

US cardiology·2024
Same author

Left atrial appendage occlusion needs lifetime management not lifetime medications.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2024
Same journal

Successful Management of a Distal Left Main Perforation Using the Jailed-balloon Technique and Covered Stent Fenestration.

Interventional cardiology (London, England)·2026
Same journal

Complete Revascularisation in ST-elevation MI: Do We Really Buy It? Challenging the Current Approach to Bystander Percutaneous Coronary Intervention.

Interventional cardiology (London, England)·2026
Same journal

Acute Performance of the DynamX Bioadaptor in Complex Coronary Lesions: An Optical Coherence Tomography-based Evaluation.

Interventional cardiology (London, England)·2026
Same journal

Optimal Fluoroscopic Angles for Percutaneous Coronary Intervention During Mechanical Cardiopulmonary Resuscitation in Cardiac Arrest Patients.

Interventional cardiology (London, England)·2026
Same journal

Safety and Effectiveness of Hypothermia as Adjunctive Therapy in Percutaneous Coronary Intervention for ST-elevation MI: A Comprehensive Meta-analysis.

Interventional cardiology (London, England)·2026
Same journal

Ultimaster TANSEI Stent in Complex Coronary Lesions: The EPIC08 TANSEI COMPLEX Study.

Interventional cardiology (London, England)·2026
See all related articles

Related Experiment Video

Updated: Feb 12, 2026

Electrospun Nanofiber Scaffolds with Gradations in Fiber Organization
09:32

Electrospun Nanofiber Scaffolds with Gradations in Fiber Organization

Published on: April 19, 2015

10.4K

Bioresorbable Scaffolds.

Sidakpal Panaich1, Theodore Schreiber1, Cindy Grines1

  • 1Department of Cardiology, Detroit Medical Center, Michigan, US.

Interventional Cardiology (London, England)
|March 29, 2018
PubMed
Summary
This summary is machine-generated.

Bioresorbable scaffolds (BRS) offer promising vascular healing over drug-eluting stents (DES) but require larger trials. This review examines BRS evidence and clinical applicability in percutaneous coronary intervention (PCI).

Keywords:
Bioresorbable scaffoldsdrug eluting stentspercutaneous coronary intervention

More Related Videos

Elastomeric PGS Scaffolds in Arterial Tissue Engineering
08:35

Elastomeric PGS Scaffolds in Arterial Tissue Engineering

Published on: April 8, 2011

16.2K
Self-reporting Scaffolds for 3-Dimensional Cell Culture
14:49

Self-reporting Scaffolds for 3-Dimensional Cell Culture

Published on: November 7, 2013

13.7K

Related Experiment Videos

Last Updated: Feb 12, 2026

Electrospun Nanofiber Scaffolds with Gradations in Fiber Organization
09:32

Electrospun Nanofiber Scaffolds with Gradations in Fiber Organization

Published on: April 19, 2015

10.4K
Elastomeric PGS Scaffolds in Arterial Tissue Engineering
08:35

Elastomeric PGS Scaffolds in Arterial Tissue Engineering

Published on: April 8, 2011

16.2K
Self-reporting Scaffolds for 3-Dimensional Cell Culture
14:49

Self-reporting Scaffolds for 3-Dimensional Cell Culture

Published on: November 7, 2013

13.7K

Area of Science:

  • Cardiovascular Medicine
  • Biomaterials Science
  • Interventional Cardiology

Background:

  • Percutaneous coronary intervention (PCI) has evolved with stent technology, including bare metal stents (BMS), drug-eluting stents (DES), and bioresorbable scaffolds (BRS).
  • Bioresorbable scaffolds aim to promote vascular healing and restore endothelial function after resorption, offering potential advantages over current DES.
  • Initial studies show promise for BRS, but their application is largely confined to clinical trials with limited real-world data.

Purpose of the Study:

  • To review the existing evidence on bioresorbable scaffolds (BRS).
  • To identify the current clinical applicability of BRS in interventional cardiology practice.
  • To highlight the need for further data from larger randomized controlled trials.

Main Methods:

  • Literature review of studies on bioresorbable scaffolds in percutaneous coronary intervention.
  • Analysis of clinical outcomes and safety data from available trials.
  • Evaluation of the transition from metallic stents to bioresorbable alternatives.

Main Results:

  • Bioresorbable scaffolds demonstrate potential physiologic advantages over drug-eluting stents.
  • Promising initial results have been observed, but often from small sample size studies.
  • Real-world applicability of BRS is currently limited, with data from larger trials pending.

Conclusions:

  • Bioresorbable scaffolds represent a significant technological advancement in coronary stenting.
  • Further robust clinical evidence from large-scale trials is necessary to establish the definitive role of BRS in routine practice.
  • The review aims to guide interventional cardiologists in assessing the current utility of BRS.